Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease

BACKGROUND: Dimebon is a retired non-selective antihistamine drug currently being investigated as a therapeutic agent for the treatment of Alzheimer's disease (AD). Results from several completed clinical trials are mixed and contradictory. Proper interpretations of these clinical observations,...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Wang, Jun, Ferruzzi, Mario G, Varghese, Merina, Qian, Xianjuan, Cheng, Alice, Xie, Mathew, Zhao, Wei, Ho, Lap, Pasinetti, Giulio M
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2011
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3035024/
https://ncbi.nlm.nih.gov/pubmed/21247479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1326-6-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires